These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11440452)

  • 1. Intraarterial recombinant tissue plasminogen activator for ischemic stroke: an accelerated dosing regimen.
    Coplin WM; Broderick J; Tomsick TT
    Neurosurgery; 2001 Jul; 49(1):228-9. PubMed ID: 11440452
    [No Abstract]   [Full Text] [Related]  

  • 2. Contemporary acute ischemic stroke therapy with intravenous recombinant tissue plasminogen activator.
    Frank JI
    Clin Neurosurg; 2000; 46():261-6. PubMed ID: 10944682
    [No Abstract]   [Full Text] [Related]  

  • 3. Stroke in the puerperium treated with intra-arterial rt-PA.
    Rønning OM; Dahl A; Bakke SJ; Hussain AI; Deilkås E
    J Neurol Neurosurg Psychiatry; 2010 May; 81(5):585-6. PubMed ID: 20460599
    [No Abstract]   [Full Text] [Related]  

  • 4. Intraarterial recombinant tissue plasminogen activator for ischemic stroke: an accelerating dosing regimen.
    Qureshi AI; Suri MF; Shatla AA; Ringer AJ; Fessler RD; Ali Z; Guterman LR; Hopkins LN
    Neurosurgery; 2000 Aug; 47(2):473-6; discussion 477-9. PubMed ID: 10942026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperacute stroke therapy with tissue plasminogen activator.
    Alberts MJ
    Am J Cardiol; 1997 Aug; 80(4C):29D-34D; discussion 35D-39D. PubMed ID: 9284041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous recombinant tissue plasminogen activator administered after 3 h following onset of ischaemic stroke: a metaanalysis.
    Maiser SJ; Georgiadis AL; Suri MF; Vazquez G; Lakshminarayan K; Qureshi AI
    Int J Stroke; 2011 Feb; 6(1):25-32. PubMed ID: 21205237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombolysis in acute ischemic stroke.
    Lang W; Domanovits H; Görzer H; Germann P; Gatterbauer E; Segall B
    Acta Anaesthesiol Scand Suppl; 1997; 111():34-7. PubMed ID: 9420947
    [No Abstract]   [Full Text] [Related]  

  • 8. Ischemic stroke and excellent recovery after administration of intravenous tissue plasminogen activator.
    Jain SV; Morton LD
    Pediatr Neurol; 2008 Feb; 38(2):126-9. PubMed ID: 18206794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy for early reperfusion after stroke.
    Juttler E; Kohrmann M; Schellinger PD
    Nat Clin Pract Cardiovasc Med; 2006 Dec; 3(12):656-63. PubMed ID: 17122798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous tissue plasminogen activator for acute stroke in California: recipients and resources.
    Birbeck GL; Cui X; Zingmond DS; Vickrey BG
    Cerebrovasc Dis; 2004; 17(4):341-3. PubMed ID: 15103183
    [No Abstract]   [Full Text] [Related]  

  • 11. Intra-arterial third-generation recombinant tissue plasminogen activator (reteplase) for acute ischemic stroke.
    Qureshi AI; Ali Z; Suri MF; Kim SH; Shatla AA; Ringer AJ; Lopes DK; Guterman LR; Hopkins LN
    Neurosurgery; 2001 Jul; 49(1):41-8; discussion 48-50. PubMed ID: 11440458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ischemic strokes arriving too late for tPA are an ideal and ethical control group for continuing studies of tPA efficacy.
    Robinson L
    Stroke; 1998 Jul; 29(7):1476-7. PubMed ID: 9660407
    [No Abstract]   [Full Text] [Related]  

  • 13. Recombinant tissue plasminogen activator: in my community hospital ED, will early administration of rt-PA to patients with the initial diagnosis of acute ischemic stroke reduce mortality and disability?
    Wyer PC; Osborn HH
    Ann Emerg Med; 1997 Nov; 30(5):629-38. PubMed ID: 9360575
    [No Abstract]   [Full Text] [Related]  

  • 14. Is intra-arterial thrombolysis safe after full-dose intravenous recombinant tissue plasminogen activator for acute ischemic stroke?
    Shaltoni HM; Albright KC; Gonzales NR; Weir RU; Khaja AM; Sugg RM; Campbell MS; Cacayorin ED; Grotta JC; Noser EA
    Stroke; 2007 Jan; 38(1):80-4. PubMed ID: 17122433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra-arterial thrombolysis: tissue plasminogen activator and other thrombolytic agents.
    Samaniego EA; Linfante I; Dabus G
    Tech Vasc Interv Radiol; 2012 Mar; 15(1):41-6. PubMed ID: 22464301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview: hyperacute rt-PA stroke treatment. The NINDS rt-PA Stroke Study Group.
    Donnarumma R; Kongable G; Barch C; Braimah J; Bratina P; Daley S; Rapp K; Sailor S; Spilker J
    J Neurosci Nurs; 1997 Dec; 29(6):351-5. PubMed ID: 9479655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroradiologists intervene with new therapy for stroke.
    Sandrick K
    Diagn Imaging (San Franc); 1999 Jan; 21(1):19-20. PubMed ID: 11692376
    [No Abstract]   [Full Text] [Related]  

  • 18. Thrombolysis with tissue plasminogen activator: protocol violation is not an option.
    Kumar S
    Neurol India; 2007; 55(2):174; author reply 174-5. PubMed ID: 17558129
    [No Abstract]   [Full Text] [Related]  

  • 19. Sex-based differences in response to recombinant tissue plasminogen activator in acute ischemic stroke.
    Mann J
    Stroke; 2005 May; 36(5):929; author reply 929. PubMed ID: 15867164
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy and safety of i.v. alteplase therapy up to 4.5 hours after acute ischemic stroke onset.
    Otwell JL; Phillippe HM; Dixon KS
    Am J Health Syst Pharm; 2010 Jul; 67(13):1070-4. PubMed ID: 20554592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.